VBI Vaccines Inc.
VBI Vaccines Inc., a pioneering biotechnology company headquartered in the United States, focuses on developing innovative vaccines to address significant global health challenges. Founded in 2010, VBI has made notable strides in the vaccine industry, particularly with its proprietary enveloped virus-like particle (eVLP) platform, which enhances the immune response and offers a unique approach to vaccine development. With operational regions extending across North America and Europe, VBI Vaccines is dedicated to advancing its core products, including vaccines for infectious diseases and immuno-oncology. The company has achieved significant milestones, including promising clinical trial results that position it as a key player in the vaccine market. VBI's commitment to scientific excellence and its unique technological advancements underscore its role in shaping the future of vaccine innovation.
DitchCarbon Score
How does VBI Vaccines Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
VBI Vaccines Inc.'s score of 17 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
VBI Vaccines Inc.'s reported carbon emissions
VBI Vaccines Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and formal commitments suggests that VBI Vaccines Inc. may not yet have established a comprehensive framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for VBI Vaccines Inc. to consider developing and communicating its climate commitments to align with broader environmental goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
VBI Vaccines Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
